Privia Health (PRVA) Insider Shawn Buys $176K of Stock

On June 26, 2026, Morris Matthew Shawn made a notable move by purchasing 88,110 shares of Privia Health Group, Inc. (NasdaqGS: PRVA) at a price of $2.00 per share. This transaction, valued at $176,220, was not part of a pre-planned trading program.

Insider Buying and Selling at Privia Health Group, Inc.

Morris Matthew Shawn was not the only insider trading shares of Privia Health Group recently. On June 29, 2026, he sold 63,212 shares, while David Mountcastle, the EVP & Chief Financial Officer, bought 17,196 shares at $2.00 on June 26, 2026, also under unplanned circumstances.

Other Institutional Activity in Privia Health Group

Several institutional investors have also been active in Privia Health Group. BlackRock, Inc. increased its holdings by 93,747 shares, bringing its total to 19,057,910 shares valued at approximately $392.02 million. FMR LLC boosted its stake by 995,493 shares to hold 13,045,542 shares worth about $268.35 million, marking an 8.3% increase. Vanguard Portfolio Management LLC initiated a new position with 6,281,542 shares valued at $129.21 million. Meanwhile, Rubicon Founders LLC added 175,142 shares, increasing its holdings by 3% to a total of 5,948,664 shares valued at $122.36 million.

Privia Health Group, Inc. Stock Up 28.7%

Shares of Privia Health Group traded near $25.55 on Wednesday. The company has a market cap of $3.24 billion and a P/E ratio of 151.35, reflecting its growth expectations. The stock's 52-week range is between $18.77 and $26.51, with a 50-day moving average of $23.27 and a 200-day moving average of $23.34. Privia Health maintains a current ratio of 1.61 and a debt-to-equity ratio of 1.12, indicating solid financial health.

Analysts Set New Price Targets

Analyst opinions on Privia Health Group are varied. On May 26, 2026, Barclays maintained a 'hold' rating with a $24.00 price target. Canaccord Genuity has a 'buy' rating with a target of $34.00 set on May 8, 2026. The consensus target price among analysts is $31.42, with 19 opinions contributing to this average.

About Privia Health Group

Privia Health Group, Inc. is a healthcare company based in Arlington, Virginia. It partners with physician practices, health plans, and health systems across the United States to improve healthcare delivery. The company offers technology solutions and management services that help reduce administrative burdens for healthcare providers. Privia Health also operates accountable care organizations to enhance patient care and reduce costs. Led by CEO Parth Mehrotra, the company employs over 1,200 people.

Bottom Line

Insider actions at Privia Health Group, like Morris Matthew Shawn's recent purchase, can offer insights into the company's internal sentiment. Investors often watch these moves closely, although they shouldn't be seen as definitive signals of future performance. Privia Health's strong financial metrics and active institutional interest highlight its position in the healthcare sector. As always, it's crucial to remember that insider transactions and institutional filings are historical and may not reflect the current state of holdings.